Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Retained Earnings (2016 - 2025)

Conmed (CNMD) has disclosed Retained Earnings for 16 consecutive years, with $588.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 1100.33% year-over-year to $588.8 million, compared with a TTM value of $588.8 million through Dec 2025, up 1100.33%, and an annual FY2025 reading of $588.8 million, up 1100.33% over the prior year.
  • Retained Earnings was $588.8 million for Q4 2025 at Conmed, up from $572.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $588.8 million in Q4 2025 and bottomed at -$59.5 million in Q3 2021.
  • Average Retained Earnings over 5 years is $186.3 million, with a median of -$27.0 million recorded in 2021.
  • The sharpest move saw Retained Earnings soared 18022.99% in 2023, then crashed 113.01% in 2024.
  • Year by year, Retained Earnings stood at -$54.2 million in 2021, then skyrocketed by 104.61% to $2.5 million in 2022, then skyrocketed by 18022.99% to $452.5 million in 2023, then plummeted by 113.01% to -$58.9 million in 2024, then surged by 1100.33% to $588.8 million in 2025.
  • Business Quant data shows Retained Earnings for CNMD at $588.8 million in Q4 2025, $572.0 million in Q3 2025, and $575.4 million in Q2 2025.